Elanor Commercial Property Fund

ECF

Elanor Commercial Property Fund is a real estate investment trust investing in commercial office assets. The company is headquartered in Sydney, New South Wales. The company went IPO on 2019-12-06. The Fund’s investment property portfolio comprised nine commercial properties in Australia. The Fund’s objective is to provide risk-adjusted returns through a combination of regular distributions and capital growth. The Fund’s investment strategy includes investing in commercial office properties located in metropolitan areas or established commercial precincts; implement leasing and active asset management to grow the income and value of the properties; acquiring additional investment grade commercial properties; and maintain a conservative capital structure with a target Gearing range between 30% and 40%. The firm is managed by Elanor Funds Management Limited.

Ecargo Holdings Limited

ECG

eCargo Holdings Ltd. engages in the development and provision of eCommerce technologies, integrated offline, online supply chain operations, and digital commerce solutions services. The firm provides holistic solutions to brands from high-end fashion to consumer goods, beauty and healthcare and other products. The Company’s distribution network covers B2C and B2B channels providing a suite of services including marketing, trademarking, TP Management, and eCargo's own Brand Growth Program, focused on providing a platform for new brands. The firm operates B2B distribution into China, Vietnam, Cambodia, Thailand, Indonesia, Malaysia, Singapore, Australia and New Zealand.

Ebos Group Limited

EBO

EBOS Group Ltd. engages in the provision of healthcare and animal care products and services. The firm is also an Australasian animal care brand owner, product marketer, and distributor. Its segments include Healthcare, Animal Care and Corporate. The Healthcare segment incorporates the sale of healthcare products in a range of sectors, such as own brands, retail healthcare, medical devices, capital equipment, pharmacy services, and wholesale activities. The Animal Care segment incorporates the sale of animal care products in a range of sectors, own brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, Endeavour Consumer Health, ProPharma, DoseAid, TerryWhite Chemmart, and Pharmacy Wholesalers Russells, among others. Its Contract Logistics business includes Healthcare Logistics and Healthcare Logistics Clinical Trials. Its Institutional Healthcare includes Clinect, Cryomed Aesthetics and Onelink, among others.

EBR Systems Inc.

EBR

EBR Systems, Inc. engages in the development of implantable systems for wireless tissue stimulation. The company is headquartered in Sunnyvale, California. The company went IPO on 2021-11-24. The firm is engaged in developing and commercializing Wireless Stimulation Endocardially (WiSE), an implantable, cardiac pacing device able to provide stimulation to endocardial (inside the heart) heart tissue for the correction of heart rhythm conditions without requiring the use of leads. WiSE offers leadless solutions for LV Pacing, including cardiac resynchronization therapy (CRT) and conduction system pacing (CSP). The firm also offers CRT devices through the CRM subsegment under the brand names, including Visionist X4 CRT-P, Valitude X4 (CRT-P), Momentum CRT-D, Resonate X4 CRT-D, and Vigilant X4 CRT-D, among others. The firm operates various subsidiaries, which include EBR Systems (AUST) Pty. Ltd. and EBR Systems (UK) Limited, which establish clinical trials in Australia and the United Kingdom, respectively.